K

C

Canaan Partners

Crunchbase
Pitchbook
Crunchbase

Deals on record

22

Common Fundraising Type

Seed

A
AttoTude

High-speed interconnect • AI

Wing Venture Capital logo
Sutter Hill Ventures logo
Mayfield logo
Canaan Partners logo

AttoTude develops high-speed interconnect technology for AI and hyperscale data centers, enhancing speed, power, reliability, and cost efficiency.

Series B
$50M
04/01/2025
Article
P
Page

AI-powered • Government relations

Twelve Below logo
Ripple Ventures logo
Go Global Ventures logo
Garage Capital logo

Page is an AI-powered platform that tracks government activities in the U.S. and U.K. for enhanced government relations.

Seed
$2.9M
03/25/2025
Article
V
Vivace Therapeutics

Small molecule • Drug discovery

RA Capital Management logo
Cenova Capital logo
Canaan Partners logo

Vivace Therapeutics is a company that develops small molecule drugs, focusing on a novel cancer therapeutic targeting the Hippo pathway for treating mesothelioma.

Series D
$35M
03/12/2025
Article
H
HeyMilo

AI-powered • Candidate screening

Entrepreneurs Roundtable Accelerator logo
Canaan Partners logo
Alumni Ventures logo

HeyMilo provides an AI-powered platform that automates the initial candidate screening process to streamline recruitment and improve hiring efficiency.

Seed
$2.2M
03/03/2025
Article
V
Valid

Biotechnology • Bispecific antibodies

Canaan Partners logo
J Ventures logo
Neo logo

Bambusa Therapeutics Inc. develops bispecific antibodies for treating immunological and inflammatory disorders.

Seed
$5.5M
02/19/2025
Article
V
Valid

AI-enabled • Ad agency

Neo logo
J Ventures logo
Canaan Partners logo

Valid is an AI-enabled ad agency that automates campaign management and performance tracking to enhance digital advertising.

Seed
$5.5M
02/19/2025
Article
W
WiseLayer

AI • Fintech

Unpopular Ventures logo
The Fintech Fund logo
K5 Global logo
Canaan Partners logo

WiseLayer develops AI-powered digital workers that automate complex finance and accounting processes for businesses.

Seed
$7.2M
02/17/2025
Article
N
Neofin

AI • SaaS

Upload Ventures logo
Quona logo
Norte logo
Far Out Ventures logo

Neofin is an AI-powered SaaS platform that optimizes accounts receivable processes for businesses.

Seed
$7M
02/05/2025
Article
W
WiseLayer

AI • Fintech

Unpopular Ventures logo
The Fintech Fund logo
K5 Global logo
Canaan Partners logo

WiseLayer develops AI-powered digital workers that automate complex finance and accounting processes for businesses.

Equity
$7.2M
01/28/2025
Article
N
Normunity

Biotechnology • T cell engager

Samsara BioCapital logo
Regeneron Ventures logo
Pfizer Ventures logo
Osage Venture Partners logo

Normunity is a biotechnology company developing anti-cancer therapies that target novel tumor-specific mechanisms to engage T cells and suppress immune evasion in solid tumors.

Series B
$75M
01/13/2025
Article
E
Enterpret

AI • Customer feedback

Wing Ventures logo
Recall Capital logo
Peak XV Partners logo
Kleiner Perkins logo

Enterpret is an AI-enabled platform that centralizes and analyzes customer feedback to enhance collaboration between product, marketing, and sales teams.

Series A
$20.8M
12/04/2024
Article
N
Nivoda

Digital marketplace • Supply chain

Northzone logo
Headline logo
Canaan Partners logo
Avenir logo

Nivoda is a digital marketplace and supply chain platform for the diamond and jewelry industry, providing jewelers with access to a vast inventory and streamlined purchasing processes.

Equity
$51M
11/21/2024
Article
G
Glooko

Digital health • Chronic condition management

Georgian logo
Health Catalyst Capital logo
Canaan logo

Glooko, Inc. provides a digital health platform focused on improving health outcomes for people with chronic conditions through data insights and device integrations.

Series F
$100M
10/10/2024
Article
S
Safire Group

Safe • Impact-Resistant Electrolyte

Canaan Partners logo
Potomac Angel Capital logo
Outpost Ventures logo
MaC Venture Capital logo

Safire Technology Group, Inc. develops a patented electrolyte technology that enhances the safety of Lithium-ion batteries by preventing fires through a liquid-to-solid transformation upon impact.

Series A
$8M
09/19/2024
Article
A
AttoTude

High-speed interconnect • AI

Wing Venture Capital logo
Sutter Hill Ventures logo
Canaan Partners logo

AttoTude develops high-speed interconnect technology for AI and hyperscale data centers, enhancing speed, power, reliability, and cost efficiency.

Series A
$29M
09/10/2024
Article
Q
Quantum Circuits

Quantum computers • High-fidelity qubits

Tribeca Venture Partners logo
Tao Capital Partners logo
Sequoia Capital logo
Osage University Partners logo

Quantum Circuits develops high-fidelity quantum computers with intrinsic error detection and handling.

Series B
$60M
08/16/2024
Article
O
Otto

Fintech • Debt Management

TwelveBelow logo
Kindred Ventures logo
Canaan Partners logo
645 Ventures logo

Otto is a fintech company that offers a financial health platform focused on efficient debt management and repayment, utilizing machine learning to provide personalized repayment strategies and a consolidated view of users' debts.

Equity
$4.5M
11/13/2023
Article
J
Joor

Wholesale • Fashion

Tamarix Capital Partners logo
Macquarie Capital logo
Canaan Partners logo
Brightwood Capital logo

Joor is a digital wholesale ecosystem company that provides a platform for fashion brands and retailers to streamline the process of presenting collections, placing orders, and handling billing and payment.

Equity
$25M
10/17/2023
Article
A
Agomab

Biotech • Anti-fibrotic Therapies

Agomab Therapeutics is a Belgian biotech company developing novel treatments for fibrosis, with a pipeline of growth factor targeting antibodies and small molecule compounds.

Series C
$100.6M
10/11/2023
Article
A
Acesion Pharma

Biotech • Cardiac Therapies

Canaan logo
Novo Holdings logo
Global BioAccess Fund logo
Alpha Wave logo

Acesion Pharma is a biotech company that develops therapies for atrial fibrillation, specifically focusing on the clinical development of an SK ion channel inhibitor for chronic oral treatment.

Series B
$47.7M
09/26/2023
Article
D
Diligent

Robotics • Healthcare Technology

True Ventures logo
Northwestern Medicine Innovation logo
Next Coast logo
DNX Ventures logo

Diligent is a robotics company that develops and deploys the Moxi nursing robot, designed to assist healthcare providers by improving workflows and potentially integrating with electronic medical records.

Equity
$25M
09/21/2023
Article
A
Actio Biosciences

Biotechnology • Precision Medicine

Canaan logo
DROIA Ventures logo
EcoR1 logo
Euclidean Capital logo

Actio Biosciences is a biotechnology company that uses its proprietary platform for genetics and precision medicine to develop therapeutics for both rare and common diseases, with a focus on TRPV4 mutations for the treatment of Charcot-Marie-Tooth disease type 2C and other serious bone diseases.

Series A
$55M
09/12/2023
Article